Clinical Trials in Chicago

Showing 5401-5420 of 15,574 trials

Perimetric Testing With Virtual Reality

NCT06549010

Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is standard-of-care in glaucoma clinics and other ophthalmology and optometry practices. However, the HFA is a large device that does not allow for examination outside the clinic and can be uncomfortable for patients with limited mobility. This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients. The results of this study will potentially serve as pilot data for the design of a larger study that involves the full assessment of the VR headset and its VF test, based on various testing strategies.

Glaucoma

Envision Health Technologies, Inc.60 participantsStarted Jul 2024

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Eptinezumab in Participants With Episodic Cluster Headache

NCT04688775

The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH)

Cluster Headache, Episodic

H. Lundbeck A/S231 participantsStarted Dec 2020

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +117 more locations

Perimetric Testing With Virtual Reality

Eptinezumab in Participants With Episodic Cluster Headache

Find Trials by Condition in Chicago

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

Dietary Supplementation on Fat Oxidation

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

HAART Annuloplasty Device Valve Repair Registry

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

A Study of ZN-c5 in Subjects With Breast Cancer

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)